AstraZeneca was sued by a former senior director who claims she didn\u0027t get $125,000 in bonuses because she worked from home. Read on.
Play Video
Elmarie Bodes, who was AstraZeneca’s senior director of business transformation until January, said in the lawsuit filed in South Carolina, Sept. 19, that the company owed her a US$124,443 performance bonus and stock options valued at US$65,000 for her work last year.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYExclusive articles by Kevin Carmichael, Victoria Wells, Jake Edmiston, Gabriel Friedman and others.
National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Subscribe now to read the latest news in your city and across Canada.Daily content from Financial Times, the world's leading global business publication. Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Create an account or sign in to continue with your reading experience.Share your thoughts and join the conversation in the comments.Don't have an account?
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claimsAstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuses and stock options because she worked from home full-time. Elmarie Bodes, who was AstraZeneca's senior director of business transformation until January, said in the lawsuit filed in South Carolina state court on Tuesday that she was owed a $124,000 performance bonus and $65,000 in stock options. Instead, AstraZeneca earlier this year cut her payout in half and refused to grant any stock options because she did not come into the office at least three days per week, according to the lawsuit.
Lire la suite »
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claimsBy Daniel Wiessner (Reuters) - AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to ...
Lire la suite »
AstraZeneca Sued by Staffer Whose Bonus Was Cut for Working at HomeAstraZeneca Plc was sued by a former senior director who claims the drugmaker refused to pay her more than $125,000 in bonuses because she worked from home last year.
Lire la suite »
AstraZeneca and Daiichi's breast cancer drug meets goal in study(Reuters) - AstraZeneca said on Friday a drug it is developing with Daiichi Sankyo's to treat patients with a type of breast cancer met one of the ...
Lire la suite »
AstraZeneca and Daiichi's breast cancer drug meets goal in study(Reuters) - AstraZeneca said on Friday a drug it is developing with Daiichi Sankyo's to treat patients with a type of breast cancer met one of the ...
Lire la suite »
AstraZeneca, Daiichi Breast Cancer Drug Shows BenefitsA drug from AstraZeneca Plc and Daiichi Sankyo Co. showed favorable results in a trial for a common type of breast cancer, in a sign it could become a top seller for the British pharmaceutical company.
Lire la suite »